CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.930
+0.030 (1.58%)
At close: Sep 5, 2025, 4:00 PM
1.890
-0.040 (-2.07%)
After-hours: Sep 5, 2025, 4:00 PM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $22.27 million as of September 5, 2025. Its market cap has increased by 14.88% in one year.
Market Cap
22.27M
Enterprise Value
18.97M
1-Year Change
14.88%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $22.27M, a decrease of -51.71%. That is a compound annual growth rate of -26.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 22.27M | -43.24% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |